Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

BioMarin

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of BioMarin's 2012 metabolic sales performance.

Pharma deals during November 2014

Pharma deals during November 2014 BioMarin was awarded a Rare Pediatric Disease PRV when it received approval of Vimizim, a new biological product for patients with Mucopolysaccharidosis type IVA. ... In July, BioMarin sold its PRV to Regeneron for $68m to expedite filing of its

Deal Watch table for November 2014

Deal Watch table for November 2014 Licence. 935. Prosensa / BioMarin. Drisapersen – for Duchenne muscular dystrophy.

Ziarco appoints Mike Grey to board of directors

Ziarco appoints Mike Grey to board of directors Grey is currently on the boards of BioMarin Pharma, Horizon Pharma, Mirati Therapeutics and Selventa.

PCSK9 inhibitor alirocumab works in statin-intolerance

PCSK9 inhibitor alirocumab works in statin-intolerance BioMarin by the FDA.

Amgen files lawsuit to block PCSK9 rivals

Amgen files lawsuit to block PCSK9 rivals to BioMarin by the FDA that could mean it gets approval within six months of filing.

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Cell and gene therapy
Tackling the manufacturing cost and complexity challenges...

Infographics